Literature DB >> 14671324

Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.

Neil M Wolfman1, Alexandra C McPherron, William N Pappano, Monique V Davies, Kening Song, Kathleen N Tomkinson, Jill F Wright, Liz Zhao, Suzanne M Sebald, Daniel S Greenspan, Se-Jin Lee.   

Abstract

Myostatin is a transforming growth factor beta family member that acts as a negative regulator of skeletal muscle growth. Myostatin circulates in the blood of adult mice in a noncovalently held complex with other proteins, including its propeptide, which maintain the C-terminal dimer in a latent, inactive state. This latent form of myostatin can be activated in vitro by treatment with acid; however, the mechanisms by which latent myostatin is activated in vivo are unknown. Here, we show that members of the bone morphogenetic protein-1/tolloid (BMP-1/TLD) family of metalloproteinases can cleave the myostatin propeptide in this complex and can thereby activate latent myostatin. Furthermore, we show that a mutant form of the propeptide resistant to cleavage by BMP-1/TLD proteinases can cause significant increases in muscle mass when injected into adult mice. These findings raise the possibility that members of the BMP-1/TLD family may be involved in activating latent myostatin in vivo and that molecules capable of inhibiting these proteinases may be effective agents for increasing muscle mass for both human therapeutic and agricultural applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671324      PMCID: PMC307655          DOI: 10.1073/pnas.2534946100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.

Authors:  S Maeda; D D Dean; I Gay; Z Schwartz; B D Boyan
Journal:  J Bone Miner Res       Date:  2001-07       Impact factor: 6.741

2.  Bone morphogenetic protein-1 processes probiglycan.

Authors:  I C Scott; Y Imamura; W N Pappano; J M Troedel; A D Recklies; P J Roughley; D S Greenspan
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

3.  Functional improvement of dystrophic muscle by myostatin blockade.

Authors:  Sasha Bogdanovich; Thomas O B Krag; Elisabeth R Barton; Linda D Morris; Lisa-Anne Whittemore; Rexford S Ahima; Tejvir S Khurana
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

4.  Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.

Authors:  Jennifer J Hill; Yongchang Qiu; Rodney M Hewick; Neil M Wolfman
Journal:  Mol Endocrinol       Date:  2003-02-20

5.  Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.

Authors:  Kathryn R Wagner; Alexandra C McPherron; Nicole Winik; Se-Jin Lee
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

6.  Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.

Authors:  Lisa-Anne Whittemore; Kening Song; Xiangping Li; Jane Aghajanian; Monique Davies; Stefan Girgenrath; Jennifer J Hill; Mary Jalenak; Pamela Kelley; Andrea Knight; Rich Maylor; Denise O'Hara; Adele Pearson; Amira Quazi; Stephanie Ryerson; Xiang Yang Tan; Kathleen N Tomkinson; Geertruida M Veldman; Angela Widom; Jill F Wright; Steve Wudyka; Liz Zhao; Neil M Wolfman
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

7.  The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum.

Authors:  Jennifer J Hill; Monique V Davies; Adele A Pearson; Jack H Wang; Rodney M Hewick; Neil M Wolfman; Yongchang Qiu
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

8.  Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases.

Authors:  William N Pappano; Barry M Steiglitz; Ian C Scott; Douglas R Keene; Daniel S Greenspan
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.

Authors:  R M Lyons; J Keski-Oja; H L Moses
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

10.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.

Authors:  Y Sato; D B Rifkin
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  159 in total

Review 1.  Metalloproteinases in Drosophila to humans that are central players in developmental processes.

Authors:  Alison Muir; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

2.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

3.  Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Kevin J Morine; Lawrence T Bish; Joshua T Selsby; Jeffery A Gazzara; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; Se-Jin Lee; H Lee Sweeney
Journal:  Muscle Nerve       Date:  2010-11       Impact factor: 3.217

4.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

5.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 6.  Diverse biological functions of extracellular collagen processing enzymes.

Authors:  Philip C Trackman
Journal:  J Cell Biochem       Date:  2005-12-01       Impact factor: 4.429

7.  Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

Authors:  Se-Jin Lee; Lori A Reed; Monique V Davies; Stefan Girgenrath; Mary E P Goad; Kathy N Tomkinson; Jill F Wright; Christopher Barker; Gregory Ehrmantraut; James Holmstrom; Betty Trowell; Barry Gertz; Man-Shiow Jiang; Suzanne M Sebald; Martin Matzuk; En Li; Li-Fang Liang; Edwin Quattlebaum; Ronald L Stotish; Neil M Wolfman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

8.  Fundamental study of detection of muscle hypertrophy-oriented gene doping by myostatin knock down using RNA interference.

Authors:  Tohru Takemasa; Naohisa Yakushiji; Dale Manjiro Kikuchi; Custer Deocaris; Masanao Machida; Hidenori Kiyosawa
Journal:  J Sports Sci Med       Date:  2012-06-01       Impact factor: 2.988

9.  High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.

Authors:  Michiko Yamada; Ryuichi Tatsumi; Keitaro Yamanouchi; Tohru Hosoyama; Sei-ichi Shiratsuchi; Akiko Sato; Wataru Mizunoya; Yoshihide Ikeuchi; Mitsuhiro Furuse; Ronald E Allen
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

10.  Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.

Authors:  Chunping Qiao; Juan Li; Hui Zheng; Janet Bogan; Jianbin Li; Zhenhua Yuan; Cheng Zhang; Dan Bogan; Joe Kornegay; Xiao Xiao
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.